Protected Pea Protein Extract and Satiety Hormone Release
Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · Jun 11, 2013
Trial Information
Current as of June 26, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy men/women
- • BMI between 18 and 25 kg/m2
- • Consistently stable body weight for at least 6 months (± 2 kg)
- Exclusion Criteria:
- • Type 2 diabetes mellitus (defined as fasting plasma glucose ≥ 7.0 mmol/L);
- • Gastroenterological diseases or abdominal surgery (uncomplicated appendectomy, cholecystectomy and hysterectomy allowed, and other surgery upon judgment of the principle investigator);
- • Cardiovascular diseases, cancer, liver or kidney malfunction, auto-immune diseases, disease with a life expectancy shorter than 5 years;
- • Abuse of products; alcohol (\>20 alcoholic consumptions per week) and drugs
- • Smoking
- • Plans to lose weight or following a hypocaloric diet;
- • Use of any medication, including vitamin supplementation, except oral contraceptives, within 14 days prior to testing;
- • Regular use of laxation products;
- • Use of antibiotics in the 90 days prior to the start of study.
- • Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study (to be decided by the principle investigator), in the 90 days prior to the study
- • Known pregnancy, lactation (checked by a pregnancy test before start of study)
- • Blood donation within 3 months before study period
- • Self-admitted HIV-positive state
About Maastricht University Medical Center
Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Maastricht, Limburg, Netherlands
Patients applied
Trial Officials
A.A.M. Masclee, Professor
Principal Investigator
Department of Internal Medicine, Division of Gastroenterology-Hepatology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials